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Background: Melastoma malabathricum (MM) Linn leaves traditionally use in the treatment of diabetic conditions.
The aim of the present investigation was to evaluate the antioxidant, antihyperlipidemic and antidiabetic activity of
methanolic extract taken from Melastoma malabathricum Linn (Melastomaceae).
Methods: The methanolic leaves extract of MM Linn leaves used for the study. Chemical test of different extract,
acute toxicity study and oral glucose test was performed. Diabetes was induced in rat by single intra-peritoneal
injection of streptozotocin (55 mg/kg). The rats were divided into following groups: Group I – normal control,
Group II (Vehicle) – diabetic control, Group III (STZ-toxic) – MM I (100 mg/kg, p.o.), Group IV – MM II (250 mg/kg, p.
o.), Group V – MM III (500 mg/kg, p.o.), Group VI – glibenclamide (10 mg/kg, p.o.). Bodyweight of each rat in the
different groups was recorded daily. Biochemical and antioxidant enzyme parameters were determined on day 28.
Histology of different organ (heart, liver, kidney, and pancreas) was performed after sacrificing the rats with
euthanasia.
Results: The methanolic extract of MM did not show any acute toxicity up-to the dose of 2000 mg/kg and shown
better glucose utilization in oral glucose tolerance test. Orally treatment of different doses of MM leaves extract
decreased the level of serum glucose, glycated hemoglobin, glucose-6-phosphatase, fructose-1-6-biphosphate and
increased the level of plasma insulin, hexokinase. MM treatment decreased liver malondialdehyde but increased the
level of superoxide dismutase, catalase and glutathione peroxidase. In oral glucose tolerance test observed
increased utilization of glucose. Streptozotocin induced diabetes groups rat treated with different doses of MM
leaves extract and glibenclamide significantly increased the body weight. Histopathology analysis on different organ
of STZ (streptozotocin) induced diabetic rat show there regenerative effect on the liver, kidney, heart and pancreas.
Conclusion: The antioxidant, antihyperlipidemic and antidiabetic effect of methanolic extract from Melastoma
malabathricum Linn suggests a potential therapeutic treatment to antidiabetic conditions.
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Diabetes mellitus (DM) is a chronic complication of de-
rangement of protein carbohydrate and lipid metabolism
characterized by increased blood glucose level resulting
from the defects in insulin secretion insulin action or
both [1]. DM is the worldwide problem to leading micro
vascular and macrovascular complications [2]. DM is a* Correspondence: phvikas@gmail.com
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stated.chronic complication that affected an estimated 135 mil-
lion people in 1995, 285 million people worldwide in
2010 and data reached approx 500 million people in
2025 mainly increasing in rural and poor population
throughout the world [3].
In hyperglycemic condition continuous generation of
reactive oxygen species (ROS) occurred. Reactive oxygen
species increased the oxidative stress mainly due to over
production of oxygen free radicals, as oxidative stress
play an important role in development of diabetes. Oxi-
dative stress effect the endogenous antioxidant, whichLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ous oxygen radicals [4]. Antioxidant play an important
role in the scavenging the free radical, damage the react-
ive oxygen species and protect the human body from
oxidative stress [5]. Hence, drug with both antioxidant
and antidiabetic property would be useful for the treat-
ment of the diabetic patient [6]. Medicinal plant is the
rich source of various chemical constituent which act on
a variety of mechanism to cure the diabetes. Therefore
the present study was carried out to evaluate the anti-
oxidant, antihyperlipidemic and antidiabetic effect of
Melastoma malabathricum Linn leaves.
Melastoma malabathricum Linn (MM) is a small
shrub from the family Melastomaceae commonly
found in tropical and temperate Southeast Asian coun-
tries, is locally known to the Malay as Senduduk, India
as Phutki. Melastoma malabathricum consists of three
different varieties, having dark purple-magenta petals
flower found in India, other dark purple-magenta
petals, light pink-magenta petals and other rare variety
having white petals [7]. Generally, different part of the
Melastoma malabathricum are used in folk medicine
to treatment of dysentery, diarrhea, hemorrhoids,
leucorrhoea, wounds and cut mainly in India, Malay
and Indonesia. Other used infection during confine-
ment and also used to prevent scarring of smallpox
and piles [8,9].
Despite long traditional use ofMelastoma malabathricum
leaves in diabetes, no systematic phytochemical and
pharmacological work has been carried out on this potential
medicinal plant. Therefore the aim of the present study is to
find out antioxidant, antihyperlipidemic and antidiabetic




Fresh leaves of Melastoma malabathricum Linn. was
collected in the month of June, 2010 from herbal garden,
Department of Life Sciences, Dibrugarh University,
Dibrugarh, Assam, India and authenticated by Botanical
Survey of India, Shillong, India. A voucher specimen was
deposited for future reference.
Preparation of extracts
The collected leaves of Melastoma malabathricum Linn.
was washed thoroughly with water to remove the
extraporeneous matter. After washing the leaves were
dried in shade and grounded 1 kg of powder was
extracted with methanol in a Soxhlet apparatus for
3 days. The extract was filtered and the filtrate was
concentrated under reduced pressure using a rotatory
evaporator at 40°C until the extra solvent completely
dried. The yield of methanolic extract was 40%. Theextract was stored in the cooling condition in refriger-
ator at 4°C until further use. The extract was dissolved
in 1% carboxyl- methyl cellulose distilled water used for
the animal studies.
Preliminary phytochemical screening of MM extract
The methanolic extract of MM was subjected to
preliminary screening for presence of various bioactive
pharmaceutical constituents such as glycoside, alkaloids,
steroids, protein, flavonoids, tannin, terpenes and sapo-
nins [10,11] Table 1.
Animals
Healthy albino rats (Wistar strain) weight about 170-
200 g were kept in individual polyethylene cages and
maintained standard condition (12 h dark and 12 h light
circle; 25 ± 5°C; 40-60% humidity), and the animals were
fed ad libitum with normal laboratory chow standard
pellet diet, purchased from the Hindustan Liver Limited,
Mumbai, India. The animals were allowed to acclimatize
for 5 days before commencing the experiments. All the
studies were conducted in accordance with the Animal
Ethical Committee of Siddhartha Institute of Pharmacy,
Dehradun, Uttarakhand (1435/PO/a/11/CPCSEA).
Acute toxicity studies
For determination of acute toxicity studies the animals were
famished overnight and divided into five groups (n = 5). All
groups’ animals were fed with different doses of the MM
extract in increasing dose level 100, 250, 500, 1000,
2000 mg/kg body weight. The animals were continuously
observed for 2 h for the following parameters: [12].
1. Behavioral profile: restlessness, irritability, alertness
and fearfulness.
2. Neurological profile: spontaneous activity, touch
response, reactivity, pain response and gait.
3. Autonomic profile: urination and defecation.
If any contraindication and death occur after 24 h and
72 h was recorded.
Oral glucose tolerance test (OGTT)
Oral glucose tolerance test was performed in overnight
(16 h) starved normal albino wistar rat. The rats were
randomly divided into five groups (n = 6) [13].
Group I rats treated with vehicle only
Group II rats treated with MM extract 100 mg/kg body
weight
Group III rats treated with MM extract 250 mg/kg
body weight
Group IV rats treated with MM extract 500 mg/kg
body weight
Table 1 Qualitative phytochemical screening of Melastoma malabathricum leaves extract
Test name Extracts
Pet. Ether Benzene Chloroform Acetone Methanol Water
Carbohydrates - - - - - -
Proteins & Amino acids - - - + + +
Steroids + + + - - -
Saponins - - - - + +
Alkaloids - - - - - -
Tannins - - - + + +
Flavonoids - - - + + +
Glycosides - - - - - -
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Glucose 2 g/kg was fed 30 min after the administration
of different doses of MM extract and glibenclamide.
Blood was withdrawn from the tail vein at 0, 30, 60, 90
and 120 min, blood glucose level were appraised by the
GOD-POD kit (Span diagnostic).
Induction of diabetes
Diabetes was induced in the overnight fasted male albino
wistar rats by a single intraperitoneal injection (i.p.) of
streptozotocin (55 mg/kg body weight) dissolved in
0.1 M citrate buffer (pH = 4.5), Normal control rat
received citrate buffer only as vehicle. After 3 days
induction of diabetes injection of STZ blood sample was
collected from the retro-orbital of the rat eyes and
plasma, glucose level were determined. The animals
confirmed diabetic by the elevated plasma glucose levels
(200 mg/dl) were used for the study [14].
Experiment design
After induction of diabetes animals were divided into six
groups of six rats each. Group I: normal control rats
administered vehicle only
Group II: diabetic control rats administered tap water
only
Group III: tested rats administered MM extract
100 mg/kg body weight
Group IV: tested rats administered MM extract
250 mg/kg body weight
Group V: tested rats administered MM extract 500 mg/
kg body weight
Group VI: tested rats administered glibenclamide
10 mg/kg body weight
All group rats received different doses of MM extract
and glibenclamide using intragastric tube once daily for
28 days, continuously [15]. According to the acutetoxicity testing of the MM extract, the different doses
i.e. 100 mg/kg, 250 mg/kg, 500 mg/kg were selected.
Biological assays
All rats were anesthetized by diethyl ether. The blood
samples of each animal were collected from the
puncturing retro-orbital plexus and preserved with
anticoagulating agents. Blood samples were centrifuged
at 4000 rpm at 25°C for 15 min and analyzed for
assorted biochemical parameters. The serum total
cholesterol, total HDL (High density lipoprotein) choles-
terol, total LDL (Low density lipoprotein) cholesterol,
and total triglyceride were estimation done spectro-
photometrically using standard kits which include serum
insulin (Span Diagnostic, India).
Estimation of antioxidant enzymes
Antioxidant enzyme was estimated by liver homogenate,
prepared in ice chilled 10% potassium chloride solution,
was used to measure the levels and activities of
superoxide dismutase (SOD), catalase (CAT) glutathione
peroxidase (GPx) and Malondialdehyde (MDA) by the
method [16-18].
Histopathology
At 28 days all groups animal sacrificed under using mild
anesthesia and isolated the different organ (heart, liver,
pancreas and liver) of the animal for histopathology. The
isolated organ (heart, liver, pancreas and liver) tissue
fixed at 40% natural buffered formaldehyde (formalin),
dehydrated by passing through a graded series of alco-
hol, and embedded in paraffin blocks and 5 mm sections
were prepared using a semi-automated rotatory micro-
tome. Hematoxylin and eosin were used for staining.
Statistical analysis
All the data were expressed as the mean ± SEM. and
analysis of variance (ANOVA) was used for the statistical
analysis using Graph Pad Prism version 5.0 (Software
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significant when the P value was p < 0.05.Results
Preliminary phytochemical screening
Preliminary phytochemical screening of the methanolic
extract of Melastoma malabathricum showed terpenoids,
flavonoids, phenolic compound, tannins, Saponins, and
triterpenes. But the content of flavonoids and phenolic
compound were found to be more prominent in the extract
(Table 1).Acute toxicity study
An acute toxicity study of the Melastoma malabathricum
Linn leaves extract were publicized the non-toxic nature
of the drug. The different doses of the Melastoma
malabathricum Linn leaves extract were not showing any
toxic reaction or lethality at any of the doses selected until
the end of the study period. Acute toxicity of the
methanolic extract of Melastoma malabathricum revealed
the non-toxic nature of the different doses. There were no
lethality or toxic reactions found in the selected group
which received the different doses of the extract until the
end of the experimental period.Effect of MM on oral glucose tolerance test
The acute effect of different doses of MM leaves extract,
when administered 30 min, prior to glucose loading
produced significant reduction (P < 0.001) in the rise
in blood glucose levels, after glucose administration
(Table 2). The different doses of MM (100, 250 and
500 mg/kg) produced 11.76%, 19.06% and 31.84% reduc-
tion in blood glucose level at 120 min when compared
to the vehicle control. Glibenclamide drug was excursion
blood glucose level at 26.57% as compared to the vehicle





1 Glucose Control 85.4 ± 2.041 115.4 ±
2 Glucose+ 85.8 ± 0.663 105 ± 1
MM (100 mg/kg)
3 Glucose+ 86.6 ± 0.871 98.2 ± 1
MM (250 mg/kg)
4 Glucose+ 85.8 ± 1.281 89.2 ± 1
MM (500 mg/kg)
5 Glucose+ 84.8 ± 0.583 94.6 ± 1
Glibenclamide (10 mg/kg)
All values represent mean ± SEM *P < 0.05; **P < 0.01; ***P < 0.001; ANOVA, followeEffect of MM on blood glucose level
The antidiabetic effect of MM leaves extract repeated
oral administration on STZ (streptozotocin) induced dia-
betic rats was presented in Table 3. The administration
of different doses (100, 250 and 500 mg/kg) to STZ
(streptozotocin) induced diabetic rats caused signifi-
cantly(P < 0.001) decline the blood glucose level, which
was showing that the different doses of MM leaves ex-
tract was showing effect at dose dependent manner.
Maximum decline rate of blood glucose was observed
on day 28 (52.13%, 60.93% and 68.88% respectively). On
the other hand glibenclamide showing the 67.26%
excursion blood glucose level at compared to the
diabetic control groups (Figure 2). MM 500 mg/kg
exhibited maximum glucose lowering effect in STZ
(streptozotocin) induced diabetic rats compared to the
other groups rat received different doses of MM leaves
extract and glibenclamide.
Effect of MM of plasma insulin
The effect of different doses of MM leaves extract on
plasma insulin was presented in Table 3. In STZ
(streptozotocin) induced diabetic rats there is a signifi-
cant decline in the level of plasma insulin as compared
to the normal rat group (rats receiving the vehicle only).
Oral administration of different doses of MM leaves
extract, significantly (P < 0.001) increased the level of
plasma insulin. Amongst all the doses of MM 500 mg/kg
was more effective in increasing the level of plasma
insulin as compared to other doses of MM and
glibenclamide (Figure 3).
Effect of MM on glycated haemoglobin (A1c)
The administration of different doses of MM leaves ex-
tract was significantly (P < 0.001) increased the level of
glycated haemoglobin (A1c) in STZ-induced treated dia-
betic rats (Table 3). Upon administration of different
doses of MM leaves extract (100, 250 and 500 mg/kg)oral glucose tolerance test
Time (min)
60 90 120
1.077 112.6 ± 0.0509 106.9 ± 0.872 98.6 ± 0.927
.732* 101.2 ± 1.655* 98.2 ± 0.734** 87 ± 1.378***
.428* 94.6 ± 1.077** 88.6 ± 1.806*** 79.8 ± 1.497***
.655** 80.8 ± 1.985*** 73.6 ± 1.327*** 67.2 ± 0.861***
.364** 88.4 ± 1.913*** 81.4 ± 1.435*** 72.7 ± 0.872***








0 30 60 90 120
Plasma glucose (mg/dL), Gp I,
Normal Control
Plasma glucose (mg/dL), Gp II,
MM I (100 mg/kg)
Plasma glucose (mg/dL), Gp III,
MM II (250 mg/kg)
Plasma glucose (mg/dL), Gp IV,
MM III (500 mg/kg)
































Figure 1 Effect of Melastoma malabathricum Linn. (MM) on fasting plasma glucose on oral glucose tolerance test at different
concentrations on STZ induced diabetic rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05;
**P < 0.01; ***P < 0.001; P > 0.05 is considered as non-significant (ns).
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globin (A1c) in STZ-induced treated diabetic rats to a
good extend. The maximum lowering of glycated
haemoglobin (A1c) in STZ-induced treated diabetic rats
was appeared in group received MM 500 mg/kg dose
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All values represent mean ± SEM *P < 0.05; **P < 0.01; ***P < 0.001; ANOVA, followe
aCompared to vehicle control.
bCompared to diabetic control.Effect of MM on hexokinase
The level of hexokinase was observed decrease in STZ
treated group rat as compared to the normal group
(Table 3). Upon oral administration of different doses of
MM leaves extract and glibenclamide were significantly
(P < 0.001) boosting the level of hexokinase in STZ-blood glucose levels in STZ-induced diabetic rats









2.6 ± 1.965* 108.2 ± 2.922** 86.2 ± 1.428*** 90.6 ± 0.509***
.8 ± 0.584* 10.4 ± 0.601** 13 ± 0.316*** 12.6 ± 0.411***
2 ± 0.081* 2.96 ± 0.678** 2.04 ± 0.129*** 2.16 ± 0.107***
5.6 ± 1.631* 131 ± 1.871** 142.6 ± 2.015*** 140.4 ± 2.182***
.4 ± 0.509* 11.6 ± 0.611** 8.6 ± 0.712*** 9.8 ± 0.567***
.8 ± 1.158* 38.2 ± 1.068** 30 ± 0.707*** 31.8 ± 0.861***
3.2 ± 2.782* 101.4 ± 1.631** 87 ± 1.703*** 89.2 ± 1.393***
5.4 ± 1.077* 103.6 ± 1.503** 90 ± 0.707*** 93.4 ± 1.077***
1 ± 1.732* 44.8 ± 1.158** 53.8 ± 0.861*** 52.8 ± 1.655***
.72 ± 3.355* 34.08 ± 1.979** 15.4 ± 2.302*** 19.52 ± 1.547***
.08 ± 0.215* 20.72 ± 0.301** 18 ± 0.141*** 18.68 ± 0.215***
.4 ± 1.032*** 186.4 ± 1.749*** 197 ± 1.304*** 194.2 ± 1.393***
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MM I (100 mg/kg)
Fasting Plasma Glucose (mg/dL), Gp IV,
MM II (250 mg/kg)
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MM III (500 mg/kg)
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Figure 2 Effect of Melastoma malabathricum Linn. (MM) on fasting plasma glucose at different concentrations on STZ induced diabetic
rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered
as non-significant (ns).
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duced diabetic rats treated with MM leaves extract doses
500 mg/kg showing the maximum increasing the level of
hexokinase at compared to the other doses treated group
rat (Figure 5).
Effect of MM on glucose-6-phosphate
To evaluate the potency of the MM leaves extract on
STZ (streptozotocin) induced diabetic rats on glucose-
6-phosphate on diabetic rat (Table 3). The level of
glucose-6-phosphate was significantly increased in STZ
(streptozotocin) induced diabetic groups rat when
compared to the normal rat. Upon oral administration
of different doses of MM leaves extract and
glibenclamide was significantly (P < 0.001) decline the
increased level of glucose-6-phosphate. Different doses
received groups’ rat significantly decreased the level of
glucose-6-phosphate but the dose of MM extract
500 mg/kg was more effective to decline the increased




























Figure 3 Effect of Melastoma malabathricum Linn. (MM) on level of pl
rats, compared to standard drug Glibenclamide; values are mean ± SE
as non-significant (ns).Effect of MM on fructose-1-6-biphosphatase
The oral administration of different doses of MM leaves
extract and glibenclamide were significantly (P < 0.001)
decreases the level of fructose-1-6-biphosphatase in STZ
(streptozotocin) induced diabetic rats (Table 3). The
level of fructose-1-6-biphosphatase enhance in STZ
induced diabetes. STZ (streptozotocin) induced diabetic
rats treatment with different doses of MM leaves
extract was sharp decrease the level of fructose-1-6-
biphosphatase to normalize rat. The MM leaves extract
with dose 500 mg/kg shown the supreme diminish levels
of fructose-1-6-biphosphatase in comparison to other
diabetic treated group rats receiving dose of 100 mg/kg,
250 mg/kg dose of MM and 10 mg/kg of Glibenclamide
respectively (Figure 7).
Effect of MM on lipid profile
To evaluate the effect of MM leaves extract on lipid
profile level, the level of cholesterol, triglyceride, LDL
(low density cholesterol) and VLDL (very low densityFasting Plasma Insulin (µU/mL), Gp 
I, Normal Control
Fasting Plasma Insulin (µU/mL), Gp 
II, Diabetic Control
Fasting Plasma Insulin (µU/mL), Gp 
III, MM III (100 mg/kg)l
Fasting Plasma Insulin (µU/mL), Gp 
IV, MM II ( 250 mg/kg)
Fasting Plasma Insulin (µU/mL), Gp 
V, MM III ( 500 mg/kg)
Fasting Plasma Insulin (µU/mL), Gp 
VI, Glibenclamide ( 10 mg/kg)
***
asma insulin at different concentrations on STZ induced diabetic
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IV, MM II (250 mg/kg)
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Figure 4 Effect of Melastoma malabathricum Linn. (MM) on level of glycated hemoglobin (A1c)(%) at different concentrations on STZ
induced diabetic rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001;
P > 0.05 is considered as non-significant (ns).
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(high density cholesterol) was decreased in the STZ
(streptozotocin) induced diabetic rat. Oral administra-
tion of MM leaves extract was showed reduction in
cholesterol, triglyceride, LDL and VLDL compared to
the diabetic control rat group and the level of HDL was
increased compared to the diabetic control rat in a sig-
nificant manner (P < 0.001) (Table 3). MM leaves extract
at the doses of 250 mg/kg and 500 mg/kg was more
effective than 100 mg/kg in reducing the level of in
cholesterol (Figure 8), triglyceride (Figure 9), HDL
cholesterol (Figure 10), LDL cholesterol (Figure 11) and
VLDL cholesterol (Figure 12) compared to the diabetic
control rat.
Changes in body weight
Table 3 display the effect of the different doses of MM
leaves extract and glibenclamide on the body weight of
on the STZ (streptozotocin) induced diabetic rat. At the






























Figure 5 Effect of Melastoma malabathricum Linn. (MM) on level of he
induced diabetic rats, compared to standard drug Glibenclamide; val
P > 0.05 is considered as non-significant (ns).rats, diabetic control, different doses of MM leaves
extract and glibenclamide treated rats were observed
(Figure 13). Diabetic control group continued to de-
crease the weight till the end of the study. Glibenclamide
and different doses (100, 250 and 500 mg/kg) of MM
leaves extract treated rats significantly (P < 0.001) in-
creased the weight as compared to the diabetic control
rats.
Effect of MM on antioxidant enzymes
In STZ induced diabetes increase the level of SOD, GPx,
CAT and decrease the level of MDA. The level of CAT
increased due to increase production of H2O2 in dia-
betic pancreas and increase the level of SOD due to in-
creased the production of superoxide, which has been
implicated in cell dysfunction. The level of antioxidant
enzyme SOD (superoxide dismutase), CAT (catalase)
and GPx (Glutathione Peroxidase) were significantly
(P < 0.001) decreased in diabetic control groups and
level of MDA (Malonaldehyde) were significantlyHexokinase (µg/mg of Protein), Gp I, 
Normal Control
Hexokinase (µg/mg of Protein), Gp II, 
Diabetic Control
Hexokinase (µg/mg of Protein), Gp 
III, MM I (100 mg/kg)
Hexokinase (µg/mg of Protein), Gp 
IV, MM II (250 mg/kg)
Hexokinase (µg/mg of Protein), Gp 
V, MM III (500 mg/kg)
Hexokinase (µg/mg of Protein), Gp 
VI, Glibenclamide (10 mg/kg)
***
xokinase (μg/mg of protein) at different concentrations on STZ
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Figure 6 Effect of Melastoma malabathricum Linn. (MM) on level of glucose-6-phosphate at different concentrations on STZ induced
diabetic rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is
considered as non-significant (ns).
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ferent doses of MM leaves extract (100, 250 and 500
mg/kg) received groups rat signification (p < 0.001) in-
crease the level of SOD (Figure 14), CAT (Figure 15),
GPx (Figure 16) and decreased the level of MDA
(Figure 17). The result suggests that glibenclamide and
all the doses of MM leaves extract increase the level of
SOD, CAT and GPx, but MM leaves extract doses 500
mg/kg was more effective in increase the level of SOD,
CAT and GPx in diabetic rat as compared with differ-
ent doses of MM leaves extract and glibenclamide.
Effect of MM on liver
Liver histopathology studies of STZ induced diabetic rat,
the accumulation of fat was increased in the diabetes
and large area of hepatocytes taken over by macro drop-







































Figure 7 Effect of Melastoma malabathricum Linn. (MM) on level of fr
induced diabetic rats, compared to standard drug Glibenclamide; val
P > 0.05 is considered as non-significant (ns).leaves extract as the dose of MM leaves extract in-
creased, the histological condition was improved
(Figure 18). The treatment with MM (100 mg/kg) dose
shown micro droplet of fat accumulation on rat
histopathology, other dose MM (250 mg/kg) dose has
shown some micro droplet of fat accumulation on rat
liver histopathology as compared to the diabetic con-
trol and MM (100 mg/kg) dose. The treatment MM
dose (500 mg/kg) shown the rat liver histopathology
similar to the glibenclamide drugs (Figure 19).
Effect of MM on heart
Effect of Melastoma malabathricum Linn. (MM) on
STZ induced diabetic rat heart. In STZ induced diabetes
group rat histopathology shown increase the interstitial
space increased intercalated disc and increased the level
of fat deposition. The treatment starts with dose of MMFructose-1-6-bisphasphate (unit/mg of
tissue), Gp I, Normal Contrrol
Fructose-1-6-bisphasphate (unit/mg of
tissue), Gp II, Diabetic Contrrol
Fructose-1-6-bisphasphate (unit/mg of
tissue), Gp III, MM I (100 mg/kg)
Fructose-1-6-bisphasphate (unit/mg of
tissue), Gp IV, MM II (250 mg/kg)
Fructose-1-6-bisphasphate (unit/mg of
tissue), Gp V, MM III (500 mg/kg)
Fructose-1-6-bisphasphate (unit/mg of
tissue), Gp VI, Glibenclamide (10
mg/kg)
***
uctose-1-6-bisphasphate at different concentrations on STZ
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250 mg/kg)
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Cholesterol ( mg/dl), Gp VI,















Figure 8 Effect of Melastoma malabathricum Linn. (MM) on level of total cholesterol at different concentrations on STZ induced
diabetic rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is
considered as non-significant (ns).
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http://www.biomedcentral.com/1472-6882/13/222(100 mg/kg) leaves extract histopathology interstitial
space and distort intercalated disc. MM (250 mg/kg)
dose histopathology shown less space of interstitial and
distort intercalated disc. Increased MM (500 mg/kg)
dose treated animal histopathology shown normal histo-
pathology of heart (Figures 20 and 21).
Effect of MM on kidney
STZ induced diabetes in animal histopathology studies
of kidney shown inflammation in blood vessels, fat de-
position, increase in the thickness of bowman capsules
and change in size of the glomerulus. STZ induced dia-
betic rat treatment with different doses of MM leaves
extract improve the injured rat kidney with increasing
doses treatment. The treatment with MM (100 mg/kg)
dose showed improved kidney histopathology less in-
flammatory blood vessels, less fat deposition as com-























Figure 9 Effect of Melastoma malabathricum Linn. (MM) on level of tr
rats, compared to standard drug Glibenclamide; values are mean ± SE
as non-significant (ns).kg) dose shown only fat deposition no inflammatory
blood vessels and the dose MM (500 mg/kg) shown the
normal histopathology there is no inflammatory vessels
and no fat deposition (Figures 22 and 23).
Effect of MM on pancreas
Histopathology studies of pancreas of STZ induced dia-
betic rat displayed reduction of the Islets of Langerhans,
damaged or reduced the size of β cells and extensive ne-
crosis changes followed by fibrosis and atrophy. STZ in-
duced diabetic rat treated with different doses of MM
leaves extract and glibenclamide restored the necrotic
and fibrotic changes and raised the number of β cells
(Figures 24 and 25).
Discussion
The present manuscript discuses about the hypoglycemic,
antioxidant and Antidiabetic effect of methanolic leavesTriglyceride ( mg/dl), Gp I, Normal
Control
Triglyceride ( mg/dl), Gp II,
Diabetic Control
Triglyceride ( mg/dl), Gp III, MM I
( 100 mg/kg)
Triglyceride ( mg/dl), Gp IV, MM II
( 250 mg/kg)
Triglyceride ( mg/dl), Gp V, MM III
( 500 mg/kg)
Triglyceride ( mg/dl), Gp VI,
Glibenclamide ( 10 mg/kg)
***
iglyceride at different concentrations on STZ induced diabetic








HDL Cholesterol (mg/dL), Gp I, Normal
Control
HDL Cholesterol (mg/dL), Gp II,
Diabetic Control
HDL Cholesterol (mg/dL), Gp III, MM I
(100 mg/kg)
HDL Cholesterol (mg/dL), Gp VI, MM II
(250 mg/kg)
HDL Cholesterol (mg/dL), Gp V, MM III
(500 mg/kg)





















Figure 10 Effect of Melastoma malabathricum Linn. (MM) on level of HDL cholesterol at different concentrations on STZ induced
diabetic rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is
considered as non-significant (ns).
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http://www.biomedcentral.com/1472-6882/13/222extract of Melastoma malabathricum on normal and
streptozotocin (STZ) induced diabetic wistar rats.
Streptozotocin (STZ) is a nitrosourea compound
(cytotoxic compound) obtained from soil microbe
Streptomyces achromogenes, is mediated by reactive
oxygen species (ROS). Streptozotocin (STZ) specially
penetrates the β-cells via glucose transporter and
induce the DNA strand breakage in β-cells causing
decrease the endogenous insulin release [19]. The
breakage of DNA is due to nitrourea moiety. This
breakage of DNA strand leads to amendment the blood
sugar level and glucose concentrations in blood.
Certain changes start after the administration of
Streptozotocin (STZ), two hours after Streptozotocin
(STZ) administration, hyperglycemia develops with a
concomitant plunge in insulin level [20]. After six
hours, hyperglycemia develops with high levels of insulin.





























Figure 11 Effect of Melastoma malabathricum Linn. (MM) on level of L
diabetic rats, compared to standard drug Glibenclamide; values are m
considered as non-significant (ns).in insulin levels [21]. In the present investigation the
antidiabetic effect of Melastoma malabathricum reported
first time.
Oral glucose tolerance test is used to identify the al-
tered carbohydrate metabolism during post glucose ad-
ministration. The ability of methanolic extract of MM to
lower the blood glucose level in oral glucose tolerance
test suggest that rats treated with different doses of
MM extract have better glucose utilization capacity
[22]. The results suggest that increased levels of
glucose tolerance in different doses of MM extract
treated groups were due to insulin emission from β-
cells and glucose improved glucose transport and
consumption [23].
In Streptozotocin (STZ) induced diabetes groups rat,
there is a loss in body weight due to muscle destruction
or degradation of structural proteins [24]. Diabetic rats
groups received different doses of MM extract andLDL Cholesterol (mg/dL), Gp I, Normal
Control
LDL Cholesterol (mg/dL), Gp II,Diabetic
Control
LDL Cholesterol (mg/dL), Gp III, MM I
(100 mg/kg)
LDL Cholesterol (mg/dL), Gp IV, MM II
(250 mg/kg)
LDL Cholesterol (mg/dL), Gp V, MM III
(500 mg/kg)
LDL Cholesterol (mg/dL), Gp VI,
Glibenclamide (10 mg/kg)
***
DL cholesterol at different concentrations on STZ induced
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Diabetic Control
VLDL Cholesterol (mg/dL), Gp III, MM I
(100 mg/kg)
VLDL Cholesterol (mg/dL), Gp IV, MM
II (250 mg/kg)
VLDL Cholesterol (mg/dL), Gp V, MM
III (500 mg/kg)






















Figure 12 Effect of Melastoma malabathricum Linn. (MM) on level of VLDL cholesterol at different concentrations on STZ induced
diabetic rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is
considered as non-significant (ns).
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http://www.biomedcentral.com/1472-6882/13/222glibenclamide significantly improve the body weight
comparison to the diabetic control group rats, all doses
of MM extract and glibenclamide showing a protective
effect in controlling muscle wasting (reversal of gluco-
neogenesis). The dose of MM extract (500 mg/kg)
showed more improvement in the body weight in com-
parison to the diabetes control and glibenclamide tested
groups.
Glibenclamide persuade insulin secretion from β cell
in the pancreas. The leaves extract of MM decreased the
serum glucose level and increased pancreatic insulin as
shown in our research exertion Therefore result suggests
that MM leaves extract may stimulate insulin secretion
and decreased serum glucose.
Streptozotocin (STZ) induced diabetes rat decrease
the level of plasma insulin. Different doses of MM ex-




















Figure 13 Effect of Melastoma malabathricum Linn. (MM) on body we
compared to standard drug Glibenclamide; values are mean ± SEM; n
non-significant (ns).insulin due to active constituent present in the plant ex-
tract which persuade insulin secretion or shield the in-
tact function β-cells from further decline so they remain
active and continue to produce insulin. The plant extract
of MM induces the protection to the β-cells, that result
in the decline of blood glucose and diminishes the
glucotoxicity to the β-cells [25]. Oral administration of
the MM extract for 28 days caused the significant
decrease in the blood glucose level with increasing the
level of plasma insulin. The possible mechanism of ac-
tion of MM extract treated groups animal could be po-
tentiating the pancreatic secretion of insulin from β-cells
of islets, as was evident by significantly elevating the
level of insulin. The hypoglycemic activity of MM ex-
tract compared with glibenclamide (standard drug), the
results suggest that the mechanism of action of MM ex-
tract and glibenclamide may be similar. Insulin is theBody Weight (g), Gp I, Normal
Control
Body Weight (g), Gp II, Diabetic
Control
Body Weight (g), Gp III, MM I (100
mg/kg)
Body Weight (g), Gp IV, MM (250
mg/kg)
Body Weight (g), Gp V, MM III
(500 mg/kg)
Body Weight (g), Gp
VI,Glibenclamide (10 mg/kg)
**
ight at different concentrations on STZ induced diabetic rats,
= 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as


















8.6 ± 0.509 3 ± 0.316*** 4.2 ± 0.374* 6.2 ± .432** 8 ± 0.323*** 7.8 ± 0.543***
2 CAT (U/mg
of protein)
72.4 ± 1.631 38.6 ± 1.327*** 46 ± 2.336* 56 ± 0.707** 68.8 ± 1.158*** 67.4 ± 1.077***
3 GPx (mMH2O2
decomposed/min)
47 ± 1.183 16.6 ± 0.927*** 25 ± 0.707* 31.6 ± 1.077** 42 ± 0.712*** 40.4 ± 0.927***
4 MDA (nmole/mg of
protein)
0.34 ± 0.027 0.66 ± 0.028*** 0.55 ± 0.017* 0.44 ± 0.011** 0.36 ± 0.012*** 0.38 ± 0.016***
All values represent mean ± SEM *P < 0.05; **P < 0.01; ***P < 0.001; ANOVA, followed by Dunnett’s multiple comparison test.
aCompared to vehicle control.
bCompared to diabetic control.
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http://www.biomedcentral.com/1472-6882/13/222most important medicine for the treatment of diabetes,
a lot of research carried out to find the substitute,
secretagogues or sensitizers from synthetic or plant
source for the treatment. Some researcher claims that
rich source of flavonoids containing plant showed the
hypoglycemic and Antidiabetic activity [26,27] and its is
reported in our research exertion that Melastoma
malabathricum leaves extract is the rich source of flavo-
noids and phenolic compound [28].
STZ induced diabetic rats’ increases the level of lipid
peroxidation (MDA), as an indirect evidence of produc-
tion of free radical [29]. In STZ induced diabetes in-
crease the level of lipid, which cause the development of
diabetes and increase the production of free radical
formation. Escalating levels of free radical play an
important role in causing the hyperglycemia, followed by
generation of reactive oxygen species (ROS). Continuous
generation of free radicals can lead to tissue dam-



























Figure 14 Effect of Melastoma malabathricum Linn. (MM) on superoxi
diabetic rats, compared to standard drug Glibenclamide; values are m
considered as non-significant (ns).unsaturated fatty acids [30], ROS to elevate the lipid per-
oxidation and alter the antioxidant defense mechanism
and further impair glucose metabolism in biological
systems [31,32]. Lipid peroxidation eventually leads to
extensive membrane damage and dysfunction [33]. Pan-
creatic β cell having low level of endogenous antioxidant
enzyme and danger to cytotoxic action of free radical. In
STZ induced diabetes the level of SOD, GPx, and CAT
was increased and the level of MDA was decreased. The
level of CAT increased due to increase production of
H2O2 in diabetic pancreas and increase the level of
SOD due to increased the production of superoxide,
which has been implicated in cell dysfunction. Increase
the level of SOD without increasing the level of GPx, in-
crease the peroxide level in the cells, cell face the
overloading of peroxide. Peroxide can react with transi-
tional metals and generates the radical hydroxyl, which
is very harmful radical [34]. On other hand increase the
level of superoxide increase the level of GPx, which isSuperoxide dismutase (U/mg
protein), Gp I, Normal Control
Superoxide dismutase ( U/mg
protein), Gp II, Diabetic Control
Superoxide dismutase ( U/mg
protein), Gp III, MM I ( 100
mg/kg)"
Superoxide dismutase ( U/mg
protein), Gp IV, MM II ( 250
mg/kg)
Superoxide dismutase ( U/mg
protein), Gp V, MM III (500
mg/kg)
* ***
de dismutase (SOD) at different concentrations on STZ induced










Catalase (U/mg protein), Gp I,
Normal Control
Catalse (U/mg protein), Gp II,
Diabetic Control
Catalase ( U/mg protein), Gp III,
MM I ( 100 mg/kg)
Catalase ( U/mg protein), Gp IV,
MM II ( 250 mg/kg)
Catalase ( U/mg protein), Gp V,
MM III ( 500 mg/kg)



















Figure 15 Effect of Melastoma malabathricum Linn. (MM) on Catalase (CAT) at different concentrations on STZ induced diabetic rats,
compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as
non-significant (ns).
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http://www.biomedcentral.com/1472-6882/13/222directly propositional to MDA (decrease the level of
MDA). Different doses of MM extract treated groups
significantly improved the level of endogenous antioxi-
dant (SOD, CAT and GPx) and prevent the membrane
to damage by decreasing lipid peroxidation compared to
diabetic control. Decreased the level of lipid peroxida-
tion (MDA as an indicator) and improved antioxidant
status may be one of the mechanism by which drug
treatment could contribute to the prevention of diabetic
complications [35].
Glycogen plays an important role in the storage of
glucose in the form of intracellular storable. Many
tissues directly an expression of insulin activity as
insulin encourage intracellular glycogen deposition by
stimulating glycogen synthesis and inhibiting glycogen
phosphorylase. The storage of liver glycogen was mark-






























Figure 16 Effect of Melastoma malabathricum Linn. (MM) on level of G
induced diabetic rats, compared to standard drug Glibenclamide; val
P > 0.05 is considered as non-significant (ns).rate, which directly affect the insulin and caused insulin
deficiency [36]. Streptozotocin (STZ) induced diabetes
rat treated with different doses of MM extract brings
back the liver glycogen near the normal rat, which in-
creases the level of insulin secretion.
Streptozotocin (STZ) induced diabetes rat enhanced
the level of glycated hemoglobin (A1c) due to excessive
production of glucose in blood which further react
with blood hemoglobin and prepared the glycated
hemoglobin [37]. Three different doses of MM extract
were significantly lower the blood glucose, which lead to
decreasing the level of glycated hemoglobin. The pos-
sible mechanism of action decreasing the blood glucose
which is directly propositional to reducing the glycated
hemoglobin.
Streptozotocin (STZ) induced diabetes rat escalating
the level of total cholesterol and triglyceride. HigherGPx (nM H2O2 decomposed/min) Gp
I, Normal Control
GPx (nM H2O2 decomposed/min) Gp
II, Diabetic Control
GPx (nM H2O2 decomposed/min) Gp
III, MM (100 mg/kg)
GPx (nM H2O2 decomposed/min) Gp
IV, MM II (250 mg/kg)
GPx (nM H2O2 decomposed/min) Gp
V, MM III (500 mg/kg)
GPx (nM H2O2 decomposed/min) Gp
II, Glibenclamide (10 mg/kg)
***
lutathione peroxidase (GPx) at different concentrations on STZ
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Figure 17 Effect of Melastoma malabathricum Linn. (MM) on level of Malondialdehyde (MDA) at different concentrations on STZ
induced diabetic rats, compared to standard drug Glibenclamide; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001;
P > 0.05 is considered as non-significant (ns).
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http://www.biomedcentral.com/1472-6882/13/222levels of cholesterol (Hypercholesteremia) and higher
level of triglyceride (Hypertriglyceridemia) are the pri-
mary factor involved in the escalation of coronary heart
disease and atherosclerosis, the secondary complications
occurring in the diabetes [38]. STZ induced diabetic
groups treated with glibenclamide and different doses of
MM leaves extract brought back the increased level of
total cholesterol and triglyceride near to the normal
levels, which could be due to that all drug treated groupFigure 18 Effect of Melastoma malabathricum Linn. (MM) on liver fat
Diabetic control: Diabetic control histopathology of rat liver shown th
kg): Tested drug histopathology shown granularity and quantity of fa
diabetic control. (D) MM II (250 mg/kg): Tested drug histopathology there
(500 mg/kg): The amount of tested drug increased and the histopathology
kg): Standard drug treated group shown histopathology similar to the norm
anatomical regions. For each group, 6 rats were examined and 50 pictures
from the 80 pictures in this group. Original magnification, 10 ×.start the increased level of insulin secretion, which in
turn, inhibit hormones sensitive lipase and increase the
utilization of glucose and decrease the mobilization of
free fatty acids from the fat depositions. STZ induced
diabetic groups increased the level of LDL (low density
lipoprotein) cholesterol increased the coronary risk fac-
tor and decreased level of HDL (high density lipopro-
tein) cholesterol shown cardiovascular risk factor. In
diabetic condition increased the level of TC and TG isaccumulation in different groups of rats: (A) Normal control: (B)
e micro fat droplet deposition (yellow arrow) (C) MM I (100 mg/
t droplet (yellow arrow) were much less compared to the
was only few micro fat droplet was present (yellow arrow). (E) MM III
similar to the glibenclamide treated group. (F) Glibenclamide (10 mg/
al control groups. The samples were obtained from the same liver
were taken. The above picture for each group was chosen randomly
Figure 19 Effect of Melastoma malabathricum Linn. (MM) on liver fat accumulation in different groups of rats: (A) Normal control:
(B) Diabetic control: Diabetic control histopathology of rat liver had shown the micro fat droplet deposition on round shape (yellow
arrow) (C) MM I (100 mg/kg): Tested drug histopathology shown small size of fat droplet (yellow arrow) as compared to the diabetic
control. (D) MM II (250 mg/kg): Tested drug histopathology shown few micro fat droplets (yellow arrow). (E) MM III (500 mg/kg): Increased
tested drug treated rat histopathology similar to the glibenclamide treated group. (F) Glibenclamide (10 mg/kg): Standard drug treated group
shown histopathology similar to the normal control groups. The samples were obtained from the same liver anatomical regions. For each group,
6 rats were examined and 50 pictures were taken. The above picture for each group was chosen randomly from the 80 pictures in this group.
Original magnification, 40 ×.
Figure 20 Effect of Melastoma malabathricum Linn. (MM) on heart in different groups of rats: (A) Normal control: Normal control group
shown normal histopathology of the heart (B) Diabetic control: Diabetic control histopathology shown increased interstitial space and distort
the intercalated disc (yellow arrow) (C) MM I (100 mg/kg): Tested drug histopathology shown decreased interstitial space and intercalated disc
(yellow arrow) (D) MM II (250 mg/kg): Tested drug histopathology shown less interstitial space (yellow arrow) (E) MM III (500 mg/kg): Tested
drug histopathology shown normal heart like the glibenclamide (F) Glibenclamide (10 mg/kg): Glibenclamide treated drug shown the normal
histopathology of heart. The samples were obtained from the same liver anatomical regions. For each group, 6 rats were examined and 50 pictures
were taken. The above picture for each group was chosen randomly from the 80 pictures in this group. Original magnification, 10 ×.
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Figure 21 Effect of Melastoma malabathricum Linn. (MM) on heart in different groups of rats: (A) Normal control: Normal control group
shown normal histopathology of the heart there is no changes in interstitial space and intercalated disc. (B) Diabetic control: Diabetic control
histopathology shown increased interstitial space, deposition of fats and distort the intercalated disc (yellow arrow) (C) MM I (100 mg/kg):
Tested drug histopathology shown decreased interstitial space and having slightly distort intercalated disc (yellow arrow) (D) MM II (250 mg/
kg): Tested drug histopathology shown less effect of interstitial space and intercalated disc (yellow arrow) (E) MM III (500 mg/kg): Tested drug
histopathology shown normal heart like the glibenclamide (F) Glibenclamide (10 mg/kg): Glibenclamide treated drug shown the normal
histopathology of heart. The samples were obtained from the same liver anatomical regions. For each group, 6 rats were examined and 50 pictures
were taken. The above picture for each group was chosen randomly from the 80 pictures in this group. Original magnification, 40 ×.
Figure 22 Effect of Melastoma malabathricum Linn. (MM) on kidney in different groups of rat: (A) Normal control: Normal control
histopathology shown 2–5 average size of glomerulus (green arrow) (B) Diabetic control: Diabetic control histopathology shown inflammatory
cell in blood vessels (red arrow) and increase the deposition of fats (yellow arrow) (C) MM I (100 mg/kg): Tested drug histopathology shown
inflammation in blood vessels (red arrow) and fat deposition (yellow arrow) (D) MM II (250 mg/kg): Tested drug histopathology shown fat
deposition (yellow arrow) and increase size of glomerulus (violet arrow) (E) MM III (500 mg/kg): Tested drug histopathology shown normal
kidney like the glibenclamide treated group (F) Glibenclamide (10 mg/kg): Glibenclamide treated animal histopathology shown the normal
kidney. The samples were obtained from the same liver anatomical regions. For each group, 6 rats were examined and 50 pictures were taken. The above
picture for each group was chosen randomly from the 80 pictures in this group. Original magnification, 10 × .
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Figure 23 Effect of Melastoma malabathricum Linn. (MM) on kidney in different groups of rat: (A) Normal control: Normal control
histopathology shown average size of glomerulus (green arrow) (B) Diabetic control: Diabetic control histopathology shown
inflammatory cell in blood vessels (red arrow) and increase the deposition of fats (yellow arrow) (C) MM I (100 mg/kg): Tested
drug histopathology shown inflammation in blood vessels (red arrow) and fat deposition (yellow arrow) (D) MM II (250 mg/kg):
Tested drug histopathology shown fat deposition (yellow arrow) and increase size of glomerulus (violet arrow) (E) MM III
(500 mg/kg): Tested drug histopathology shown normal glomerulus but slightly bigger in size (F) Glibenclamide (10 mg/kg):
Glibenclamide treated animal histopathology shown the normal kidney. The samples were obtained from the same liver anatomical
regions. For each group, 6 rats were examined and 50 pictures were taken. The above picture for each group was chosen randomly from
the 80 pictures in this group. Original magnification, 40 ×.
Figure 24 Photomicrographs of histological changes of rat pancreas of isletes of Langerhans: (A) Normal control: normal
histological structure of rat pancreas showing normal islet (green arrow) (B) Diabetic control: diabetic control rat showing dilated
acini (blue arrow) and focal necrosis (yellow arrow) (C) MM I (100 mg/kg): tested drug rat showing dilated acini (blue arrow) and
focal necrosis (yellow arrow) (D) MM II (250 mg/kg): tested drug rat showing and focal necrosis (yellow arrow) (E) MM III (500 mg/
kg): tested drug rat showing and focal necrosis (yellow arrow) (F) Glibenclamide (10 mg/kg): glibenclamide treated rat pancreas
showing normal islet (green arrow). For each group 6 rats were examined and 50 pictures were taken. The above picture for each group
was chosen randomly from the 80 pictures in this group. Original magnification, 10 ×.
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Figure 25 Photomicrographs of histological changes of rat pancreata (A) Normal control: Normal histological structure of rat
pancreata showed averaged sized islet (red arrow) and normal sized β cells (green arrow) (B) Diabetic control: Diabetic control rat
showing rat pancreata small sized (red arrow) without enlargement of β cells (yellow arrow) and showing the changes of fatty
acid (blue arrow) (C) MM I (100 mg/kg): tested drug rat showing rat pancreata small sized (red arrow) without enlargement of β
cells (yellow arrow) and showing the less changes of fatty acid (blue arrow) (D) MM II (250 mg/kg): tested drug rat showing rat
showing rat pancreata small sized (red arrow) without enlargement of β cells (yellow arrow) (E) MM III (500 mg/kg): tested drug
rat showing rat enlargement of β cells (yellow arrow) (F) Glibenclamide (10 mg/kg): glibenclamide treated rat histological
structure of rat pancreata showed averaged sized islet (red arrow) and normal sized β cells (green arrow). For each group 6 rats
were examined and 50 pictures were taken. The above picture for each group was chosen randomly from the 80 pictures in this group.
Original magnification, 40 ×.
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http://www.biomedcentral.com/1472-6882/13/222associated with increased level of LDL, VLDL and de-
creased level of HDL. In diabetic condition start the de-
position of cholesterol (LDL and VLDL) in peripheral
tissue, increased level of LDL and VLDL is atherogenic.
Now treatment of the STZ induced diabetes groups
start with the different doses of MM leaves extract sig-
nificantly reducing the serum total cholesterol, triglycer-
ide LDL, VLDL and decreased the level of MDA. The
results suggest that different doses of MM extract were
significantly lower the blood lipid abnormalities.
Liver is the vital organ and play an important role in
defense the postprandial hyperglycemia and synthesis
of glucose metabolism. The main role of the liver in
glucose utilization is to convert the glucose into glucose-
6-phasphatase by the help of hexokinase and other
role is it converts glucose into energy [39,40]. STZ in-
duced diabetic groups increased the level of glucose-6
-phasphatase, which increase the production of fats to
carbohydrates, which turn to deposition into liver,
kidney and altered the level of hexokinase, which
decreased the conversion and utilization of glucose.
Other effect in diabetes is increased the level of
fructose-1-6-phasphate. STZ induced diabetic groups
treated with different doses of MM leaves extract
and glibenclamide increased the level of hexokinase
and decrease the level of glucose-6-phasphatase andfructose-1-6-bisphasphate and bring the level near to
the normal control.
Conclusions
Thus, our findings demonstrate that different doses of MM
leaves extract has an antidiabetic, antihyperlipidemic and
antioxidant effects, which is evidenced by decreased level of
blood glucose, glycated hemoglobin, glucose-6-phasphate,
fructose-1-6-phasphate, total cholesterol, triglyceride, LDL
cholesterol, VLDL cholesterol, SOD, CAT, GPx, and in-
creased level of HDL Cholesterol, plasma insulin, hexoki-
nase, MDA,. Oral glucose tolerance test shown that MM
leaves extract having better glucose utilization capacity.
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